Sumei Xu Selected Research

raubasine (ajmalicine)

1/2022

Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sumei Xu Research Topics

Disease

3	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2022
1	Inflammation (Inflammations) 01/2022
1	Yang Deficiency (Xu, Yang) 01/2022
1	Alcoholic Fatty Liver 03/2021
1	Dysbiosis 03/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Stomach Diseases 01/2019
1	Hypertension (High Blood Pressure) 09/2017

Drug/Important Bio-Agent (IBA)

2	shenqiIBA 01/2022 - 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	kaempferolIBA 01/2022
1	DiosgeninIBA 01/2022
1	raubasine (ajmalicine)IBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	QuercetinIBA 01/2022
1	StigmasterolIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 03/2021
1	Ribosomal DNA (rDNA)IBA 03/2021
1	FlavonoidsIBA 03/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020
1	ClayIBA 01/2019
1	micaIBA 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2017
1	1,4-dihydropyridine (dihydropyridine)IBA 09/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2017
1	CalciumIBA 09/2017
1	Enalapril FDA LinkGeneric 09/2017
1	Felodipine (Agon)FDA LinkGeneric 09/2017

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022